Valeo Pharma Inc.
KIRKLAND, A8 · CIK 0001904395 · Biotech · Acquired
Pharmaceutical therapeutics in respiratory, neurology, and oncology indications
valeopharma.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $787K
- 1 Form D · Jan 2022
- 57 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $787,400 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2151 | Denali Medical II, Inc. | — | $4.0M |
| 2152 | KANNALIFE SCIENCES, INC. | — | $1.5M |
| 2153 | QRKANSWER LLC | — | — |
| 2154 | Valeo Pharma Inc. | — | $787K |
| 2155 | Falcon Therapeutics, Inc. | — | $700K |
| 2156 | Mindset Pharma Inc. | — | $694K |
| 2157 | Bitterroot Bio | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Guy-Paul AllardExecutive Officer
- Maureen BreenanDirector
- Michelle BrienExecutive Officer
- Frederic FasanoDirector · Executive Officer
- Vincent HogueDirector
- Nelly KomariExecutive Officer
- Richard MackayDirector · Executive Officer
- Luc MainvilleExecutive Officer
- Helen SaviukExecutive Officer
- Steve SaviukDirector · Executive Officer
- Jeff SkinnerExecutive Officer
- Nathalie TherrienExecutive Officer
- Michel TrudeauDirector
- Michael WellsDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.